Vol 110, No 12 (2020)

Table of Contents


Contents PDF

From the Editor

2020 and all that PDF
B Farham 1141
Thank you from SAMA and the editors PDF
B Farham 1142-1143

Guest Editorial

Colonoscopy practice in South Africa: The way forward PDF
L Katsidzira, S Thomson 1144-1145
Reporting of studies based on the analysis of routinely collected health data PDF
R P Abratt, F Macbeth 1146-1147


COVID-19 collateral damage: Alcohol rub dermatitis as an emerging problem PDF
S M Alves, A J Arendse, S M H Kannenberg 1148
Trends in paediatric tuberculosis diagnoses in two South African hospitals early in the COVID-19 pandemic PDF
L Lebina, M Dube, K Hlongwane, H Brahmbatt, S G Lala, G Reubenson, N Martinson 1149-1150
The challenges of maintaining non-COVID medicine services at Groote Schuur Hospital, Cape Town, South Africa, during COVID-19 PDF
M Sonderup, W Spearman, I Ross, N Gogela, M Combrinck, M Setshedi, G Symons, N Wearne, S Hoosain, J-J Kruger, B Mbena, D Boayke, T Muchenje, M Masikati, E Okeyo, B Makhura, J Botha, L Hlongwane, N Ntusi 1151
The economics of poisoning: The role of telemedicine and toxicovigilance PDF
K Balme, C Stephen, L Curling, F Mohamed, C du Plessis, C Marks, V Pillay-Fuentes Lorente, R van Rensburg, G Voigt 1152


Martin Marivate PDF
S Moodley 1153


Protecting healthcare workers: A critical part of the COVID-19 response PDF
L-G Bekker, S Delany-Moretlwe, B Biccard, L du Toit, L B Lovat, H-M Dehbi, R Moonesinghe, H Rees, M S Avidan 1154-1155
Access to novel therapies for COVID-19 – distributive justice and Russian roulette? PDF
M S Pepper 1156-1157

In Practice

Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease PDF
A Jaca, S Durão, J Harbron 1158-1159
Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South Africa PDF
M Loveday, H Cox, D Evans, J Furin, N Ndjeka, M Osman, K Naidoo; for the National TB Think Tank 'Optimising TB Treatment Outcomes' Task Team 1160-1167
Prolonged treatment of COVID-19 pneumonia with high-flow nasal oxygen: A story of oxygen and resilience PDF
G G Audley, P Frankenfeld, S Dlamini, P Raubenheimer, J Hoare, L Cairncross, R van den Berg, M V Gule, G Calligaro 1168-1171
Age discrimination in critical care triage in South Africa: The law and the allocation of scarce health resources in the COVID-19 pandemic PDF
N Erasmus 1172-1175
Critical care triage during the COVID-19 pandemic in South Africa: A constitutional imperative! PDF
B M Morrow, P D Gopalan, I Joubert, F Paruk, A Pope 1176-1179


Rapid evolution of our understanding of the pathogenesis of COVID-19: Implications for therapy PDF
F Mustafa, R Giles, M S Pepper 1180-1185


The ‘ins and outs’ of colonoscopy at Wits Donald Gordon Medical Centre, South Africa: A practice audit of the outpatient endoscopy unit PDF
C Bouter, P Barrow, D Bizos, B Bobat, J Devar, N Harran, C Joseph, A Mahomed, J Oettle, J Ramos, M Seabi, G Kgabage, P Gaylard, D Surridge, H Etheredge, J Fabian, D Lutrin, K Karlsson 1186-1190
Prevalence and characteristics of incidental colorectal polyps in patients undergoing colonoscopy at a South African tertiary institution PDF
J Kruger, L Katsidzira, M Setshedi, S R Thomson 1191-1194
Postmortem lung biopsies from four patients with COVID-19 at a tertiary hospital in Cape Town, South Africa PDF
C Bruce-Brand, B W Allwood, C F N Koegelenberg, U Lalla, E Louw, A H Diacon, P T Schubert 1195-1200
The impact of COVID-19 on routine patient care from a laboratory perspective PDF
E C Kruger, R Banderker, R T Erasmus, A E Zemlin 1201-1205
Use of the antenatal antiretroviral (ARV) tracking form in maternity case records to improve ARV management PDF
T P Kerry, P G T Cudahy 1206-1212
Two-year viral load suppression among adolescents receiving antiretroviral therapy in the Cape Metropole, South Africa, 2013 - 2015: A retrospective cohort analysis PDF
B E van Wyk, E Kriel, F Mukumbang 1213-1217
Repeat injuries in childhood PDF
S M Peters, M-A Davies, A B van As 1218-1225
Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa PDF
J Jones, A Swart, E Tommy, K Cohen, A Stewart, J Voget, M Blockman 1226-1230
A retrospective review of the adverse effects of biological therapy and reasons for its discontinuation in a resource-limited setting PDF
J W Rood, R du Toit 1231-1237


CPD questions PDF